4

Changes in Ownership

Aligos Therapeutics, Inc. Filed 2020-10-20 Acc 0001567619-20-018012

Director bought 200,000 shares at $15.00 ($3,000,000)

Director acquired 3,092,339 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider	Date	Transaction	Shares	Price	Value	Owned after	D/I
Woiwode Thomas Director	2020-10-20	Conversion	+2,145,991			2,145,991	I
Woiwode Thomas Director	2020-10-20	Conversion	+198,839			2,344,830	I
Woiwode Thomas Director	2020-10-20	Conversion	+85,065			2,429,895	I
Woiwode Thomas Director	2020-10-20	Conversion	+463,959			463,959	I
Woiwode Thomas Director	2020-10-20	Conversion	+198,485			662,444	I
Woiwode Thomas Director	2020-10-20	Purchase	+200,000	$15.00	$3,000,000	862,444	I
Derivatives
Woiwode Thomas Director	2020-10-20	Conversion · Series A Preferred Stock	−2,145,991			0	I
Woiwode Thomas Director	2020-10-20	Conversion · Series B-1 Preferred Stock	−198,839			0	I
Woiwode Thomas Director	2020-10-20	Conversion · Series B-1 Preferred Stock	−463,959			0	I
Woiwode Thomas Director	2020-10-20	Conversion · Series B-2 Preferred Stock	−85,065			0	I
Woiwode Thomas Director	2020-10-20	Conversion · Series B-2 Preferred Stock	−198,485			0	I
Open-market purchases · 200,000 sh · avg $15.00 · $3,000,000